Quantcast
Channel:
Viewing all 64049 articles
Browse latest View live

Global Composites Market 2012-2018 & 2022 - Market is Projected to Reach $ 42 Billion

$
0
0

Research and Markets LogoDUBLIN, June 22, 2018 /PRNewswire/ -- The "Global Composites Market By Type (Glass Fiber & Carbon Fiber), By Application (Civil Engineering, Aerospace & Defense, & Others), By Manufacturing Process (Lay Up, Injection Moulding, etc.), By Region, Competition Forecast &...



US Metal Service Center Revenue to Reach $165 Billion in 2022

$
0
0

Freedonia Group logo (PRNewsFoto/The Freedonia Group)CLEVELAND, June 22, 2018 /PRNewswire/ -- Revenues of US metal service centers are forecast to total $165 billion in 2022, according to Metal Services: United States, a report recently released by Freedonia Focus Reports. Expanding durable goods output and construction activity will boost...


One Man's Journey From Bartender to Striking 'Internet Gold' Is Inspiring Young Entrepreneurs

$
0
0
RICHMOND, Va., June 22, 2018 /PRNewswire/ -- At the age of 24, Myke Metzger finished his 4th weekend in jail for driving on a suspended license, and had just received the news that he had no bartending job to return to. Without many options left, he ventured out on his own. Now, a...

Brad Schlachter Joins Civilized As Director Of Audience Acquisition

$
0
0

Brad Schlachter Joins Civilized As Director Of Audience Acquisiion (CNW Group/Civilized Worldwide Inc. (Civilized))Schlachter is a highly accomplished digital marketer, advisor and strategist for leading entertainment and digital organizations LOS ANGELES and SAINT JOHN, NB, June 22, 2018 /PRNewswire/ - Brad Schlachter has joined Civilized as Director of Audience Acquisition. Schlachter...


Strategic Staffing Solutions Names Bob Zhang As Detroit Market Team Leader

$
0
0

Bob Zhang, Detroit Market Team Leader, Strategic Staffing SolutionsDETROIT, June 22, 2018 /PRNewswire/ -- Strategic Staffing Solutions is pleased to announce the promotion of Bob Zhang to Detroit Market Team Leader. Before serving as the Detroit MTL, Zhang served in the role of Director of Customer Care and Contact Services of S3's Customer Contact...


InsureMyTrip Upgrades Travel Insurance Recommendation Engine, Adds New Features

$
0
0

WARWICK, R.I., June 22, 2018 /PRNewswire/ -- InsureMyTrip, the first travel insurance comparison site, is celebrating the latest upgrade to its groundbreaking recommendation engine. The newest version is smarter and more precise —  capable of automatically filtering thousands of travel ins...


ModulTrade Opens Global Market for African SMEs

$
0
0

LONDON, June 22, 2018 /PRNewswire/ -- ModulTrade creates a foundation for the launch of ModulTrade blockchain based smart-contract platform (MT WALLET and MT MARKET) in the African continent after signing agreements with leading financial & logistic organizations and meeting...


Johnson Fistel Announces Investigations of Veevo Instruments Inc., Insys Therapeutics, Inc., TAL Education Group and Newell Brands Inc.; Investors Encouraged to Contact Firm

$
0
0

SAN DIEGO, June 23, 2018 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP is investigating potential claims against Veevo Instruments Inc., Insys Therapeutics, Inc., TAL Education Group and Newell Brands Inc., as detailed below: Veevo Instruments Inc.(VECO) Johnson...



Xcode Life Announces the South Asian Genome (SAGE) Project

$
0
0

The South Asian Genome (SAGE) ProjectCHENNAI, India, June 23, 2018 /PRNewswire/ -- Xcode Life, an innovative personal genomics company has announced the worldwide launch of the South Asian Genome (SAGE) Project. This is open to all individuals with known South Asian roots. All individuals who qualify the eligibility...


Ford Motor Company: Saudi Women Drive

$
0
0
RIYADH, Saudi Arabia, June 23, 2018 /PRNewswire/ -- On June 24, 2018, women in Saudi Arabia will be legally able to drive on the roads of the Kingdom. This is a momentous time in history and we are delighted to be able to welcome Saudi women "to the front", to the driver's seat....

Array BioPharma Announces a 62% Observed Overall Survival at One Year from the Phase 3 BEACON CRC Safety Lead-In of the Combination of Encorafenib, Binimetinib and Cetuximab in BRAF-Mutant CRC at the ESMO 20th World Congress on Gastrointestinal Canc

$
0
0

Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)BOULDER, Colo., June 23, 2018 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY) today announced updated safety and efficacy results, including OS, from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a...


SPA Selected as a 2018 Washington Post Top Workplace

$
0
0

https://mma.prnewswire.com/media/710071/Systems_Planning_and_Analysis_Top_Work_Places_Logo.jpg?p=captionALEXANDRIA, Va., June 23, 2018 /PRNewswire/ -- For the fifth year in a row, Systems Planning and Analysis, Inc. (SPA), has been named a Top Workplace by The Washington Post. The Washington Post's 2018 Top Workplaces are determined based on feedback collected via an anonymous employee...


Cloud With Me: Converting Cloud Adoption Into an Accessible Solution for All

$
0
0
DUBLIN, June 23, 2018 /PRNewswire/ -- What if businesses could eliminate the complexities of internet based services to improve performance? What if it was possible for employees to work from anywhere, at any time, from any device, and still have a single control point on proceedings?...

New Data Show Amgen's Repatha® (evolocumab) Significantly Reduced LDL-C And Non-HDL-C In High-risk Patients With Type 2 Diabetes

$
0
0

Amgen Logo. (PRNewsFoto/Amgen) (PRNewsFoto/)THOUSAND OAKS, Calif., June 23, 2018 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced new data that show Repatha® (evolocumab) significantly reduced low-density lipoprotein cholesterol (LDL-C) and non-high density lipoprotein cholesterol (non-HDL-C) in patients with Type 2 diabetes and...


Investigational Doses of Lilly's Once-Weekly Trulicity® (dulaglutide) Show Promise in Delivering Powerful Efficacy in People with Type 2 Diabetes

$
0
0

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company) (PRNewsfoto/Eli Lilly and Company)INDIANAPOLIS, June 23, 2018 /PRNewswire/ -- Two investigational doses of Lilly's dulaglutide (4.5 mg and 3.0 mg), as well as Trulicity® (dulaglutide) 1.5 mg, provided significantly better blood sugar control with weight benefits compared to placebo in adults with type 2 diabetes.1 Data...



Two-year Data from ViaCyte's STEP ONE Clinical Trial Presented at ADA 2018

$
0
0

ViaCyte logo. (PRNewsFoto/ViaCyte, Inc.)SAN DIEGO, June 23, 2018 /PRNewswire/ -- ViaCyte, Inc., a privately-held regenerative medicine company, today announced two-year data from Cohort 1 of the ongoing Safety, Tolerability, and Efficacy of VC-01™ (PEC-Encap™) Product Candidate in Type One Diabetes (STEP ONE) clinical trial....


Significant blood sugar improvement with Xultophy® 100/3.6 compared to insulin glargine U-100 when used as add-on to oral diabetes medications

$
0
0

ORLANDO, Fla., June 23, 2018 /PRNewswire/ -- Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL provided superior A1C reduction compared to insulin glargine U-100 (1.94% vs 1.68% respectively; p˂0.0001) when used as an add-on to a SGLT-2i (an oral dia...


Gaumard's Growing Family Takes Center Stage at AWHONN '18

$
0
0

MIAMI, June 23, 2018 /PRNewswire/ -- With women's health, obstetric and neonatal nurses taking on ever-greater responsibilities, there's no better time than AWHONN's 2018 annual convention, from today through June 27 in Tampa, to see Gaumard's growing family of maternal and neonatal...


Jardiance® reduced risk of kidney disease progression in adults with type 2 diabetes and established cardiovascular (CV) disease independent of control of conventional CV risk factors

$
0
0

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company) (PRNewsfoto/Eli Lilly and Company)RIDGEFIELD, Conn. and INDIANAPOLIS, June 23, 2018 /PRNewswire/ -- Boehringer Ingelheim and Eli Lilly and Company (NYSE: LLY) today announced findings from two new analyses of the landmark EMPA-REG OUTCOME® trial, presented at the 78th American Diabetes Association (ADA) Scientific Sessions...


New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce Potential of Lilly's Ultra Rapid Lispro in People with Type 1 and Type 2 Diabetes

$
0
0

Eli Lilly and Company logo. (PRNewsFoto, Eli Lilly and Company) (PRNewsfoto/Eli Lilly and Company)INDIANAPOLIS, June 23, 2018 /PRNewswire/ -- Eli Lilly and Company's (NYSE: LLY) ultra rapid lispro (URLi) led to improved and sustained blood sugar control after meals in people with type 1 and type 2 diabetes, according to results from three phase 1b studies evaluating URLi compared to...


Viewing all 64049 articles
Browse latest View live




Latest Images